Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.
The Royal College of Emergency Medicine
3 followers
ICON
57 followers
Lundbeck
52 followers
Jazz Pharmaceuticals
47 followers
Carpe
3 followers
Charlie Health
15 followers
Alkermes
14 followers
Montu Group
2 followers
Calico
8 followers
Ambience Healthcare
7 followers
Mineralys Therapeutics
3 followers
Persephone Biosciences
1 follower